Literature DB >> 4035815

[Complications in drug prevention of thromboembolism].

K Tittel.   

Abstract

The possibility of complications during the thrombembolic prophylaxis with heparin-dihydroergotamine requests the observance of the application and the contraindications. The information of the patients and the continuous clinical control are absolutely necessary. The thrombembolic prophylaxis with less risk is given in a sufficient medication with Heparin in connection with early active exercising and correct positioning of the patient.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4035815     DOI: 10.1007/bf02587950

Source DB:  PubMed          Journal:  Unfallchirurgie        ISSN: 0340-2649


  12 in total

1.  [Guides to ergotism, a too little recognized complication of trauma].

Authors:  J Voigt; J Dortenmann
Journal:  Aktuelle Traumatol       Date:  1983-02

2.  [The problem of ergotism in thrombosis prevention with drugs].

Authors:  G Räber; U Bauermeister
Journal:  Z Arztl Fortbild (Jena)       Date:  1983

3.  [Ergotism in heparin-dihydroergotamine therapy].

Authors:  H J Schneck; G Tempel; B Kramann
Journal:  Dtsch Med Wochenschr       Date:  1983-03-11       Impact factor: 0.628

4.  [Ergotism--a severe complication of drug prevention of thromboembolism].

Authors:  E van den Berg; G Walterbusch
Journal:  Dtsch Med Wochenschr       Date:  1982-05-07       Impact factor: 0.628

5.  [Vasospastic reactions after heparin-dihydroergotamine].

Authors:  K J Paquet
Journal:  Dtsch Med Wochenschr       Date:  1982-09-03       Impact factor: 0.628

6.  [Vasospasm during thromboembolism prevention using heparin-dihydroergotamine].

Authors:  K D Rumpf; E van den Berg; H Fröhlich
Journal:  Dtsch Med Wochenschr       Date:  1982-09-10       Impact factor: 0.628

7.  [Prinzmetal angina caused by dihydroergotamine. Acute event in the catheterization of an atrial septal defect].

Authors:  A Konrad; K Lossnitzer
Journal:  MMW Munch Med Wochenschr       Date:  1984-02-24

8.  [Ergotism--an important complication of drug therapy in prevention of thromboembolism].

Authors:  H M Echterhoff; U R Kottmann; X R Okoye; H G Rohner
Journal:  Dtsch Med Wochenschr       Date:  1981-12-11       Impact factor: 0.628

9.  [Toxic shock syndrome in pyogenic arthritis].

Authors:  J Schädelin; F Mahler
Journal:  Schweiz Med Wochenschr       Date:  1982-12-18

10.  Low dose heparin: bleeding and wound complications in the surgical patient. A prospective randomized study.

Authors:  H L Pachter; T S Riles
Journal:  Ann Surg       Date:  1977-12       Impact factor: 12.969

View more
  1 in total

1.  [Prevention of thromboembolism with heparin-DHE--safety and trends].

Authors:  R Häring; K Koppenhagen
Journal:  Langenbecks Arch Chir       Date:  1986
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.